We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
HLVX

Price
1.67
Stock movement up
+0.12 (7.74%)
Company name
Hillevax Inc
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Biotechnology
Market cap
83.18M
Ent value
15.76M
Price/Sales
29.04
Price/Book
0.45
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-
1 year return
-88.13%
3 year return
-
5 year return
-
10 year return
-
Last updated: 2025-04-11

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

DIVIDENDS

HLVX does not pay dividends or no data was received

iO Charts is a Seeking Alpha partner

VALUATION

Valuation Ratios

Loading...
Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Loading...
Valuation (Sales/Book Value) data
Price to Sales29.04
Price to Book0.45
EV to Sales5.50

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

FINANCIALS

Per share

Loading...
Per share data
Current share count49.81M
EPS (TTM)-3.04
FCF per share (TTM)-2.85

Income statement

Loading...
Income statement data
Revenue (TTM)2.86M
Gross profit (TTM)638.00K
Operating income (TTM)-135.87M
Net income (TTM)-150.28M
EPS (TTM)-3.04
EPS (1y forward)-1.61

Margins

Loading...
Margins data
Gross margin (TTM)22.28%
Operating margin (TTM)-4744.10%
Profit margin (TTM)-5247.21%

Balance Sheet

Loading...
Please create a free account or log in to access this chart
Balance Sheet data
Cash103.76M
Net receivables0.00
Total current assets197.17M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment24.08M
Total assets220.62M
Accounts payable1.21M
Short/Current long term debt24.97M
Total current liabilities13.84M
Total liabilities36.35M
Shareholder's equity184.27M
Net tangible assets0.00

Cash flow

Loading...
Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-112.21M
Capital expenditures (TTM)28.38M
Free cash flow (TTM)-140.59M
Dividends paid (TTM)0.00

Financial returns

Loading...
Please create a free account or log in to access this chart
Financial returns data
Return on Equity-81.55%
Return on Assets-68.12%
Return on Invested Capital-80.01%
Cash Return on Invested Capital-74.85%

iO Charts is a Seeking Alpha partner

STOCK INFORMATION

Stock chart

Loading...
Stock price data
Open1.57
Daily high1.70
Daily low1.56
Daily Volume359K
All-time high22.01
1y analyst estimate3.00
Beta0.77
EPS (TTM)-3.04
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Loading...
Downside potential data
HLVXS&P500
Current price drop from All-time high-92.41%-12.89%
Highest price drop-93.71%-56.47%
Date of highest drop1 Apr 20259 Mar 2009
Avg drop from high-47.20%-11.07%
Avg time to new high186 days12 days
Max time to new high648 days1805 days

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

COMPANY DETAILS
HLVX (Hillevax Inc) company logo
Marketcap
83.18M
Marketcap category
Small-cap
Description
HilleVax, Inc., a clinical-stage biopharmaceutical company, focuses on developing and commercializing novel vaccines in the United States. It develops HIL-214, a virus-like particle-based vaccine candidate for the prevention of moderate-to-severe acute gastroenteritis caused by norovirus infection. The company was formerly known as MokshaCo, Inc. and changed its name to HilleVax, Inc. in February 2021. HilleVax, Inc. was founded in 2019 and is headquartered in Boston, Massachusetts.
Employees
90
Investor relations
-
SEC filings
CEO
Country
USA
City
Stock type
-
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
Loading...

iO Charts is a Seeking Alpha partner

iO Charts is a Seeking Alpha partner

UNDERSTAND THE BUSINESS
Loading...